The Medical Letter on Drugs and Therapeutics
FROM
ISSUE 1557
ISSUE 1557
October 8, 2018
Choice of Contraceptives
| The full article is available to subscribers | Subscriber Login |
October 8, 2018 (Issue: 1557)
Intrauterine devices (IUDs) and the etonogestrel
implant are the most effective reversible contraceptive
methods available. Hormonal oral contraceptives,
patches, rings, and injectables are also highly effective
in preventing pregnancy. When used alone, barrier and
fertility-based methods generally have higher failure
rates than other methods.
... more
- ARA Aiken and J Trussell. Recent advances in contraception. F1000Prime Rep 2014; 6:113.
- J Trussell and ARA Aiken. Contraceptive efficacy. In: RA Hatcher et al. Contraceptive Technology: Twenty-first revised edition. New York, NY: Ayer Company Publishers 2018.
- KM Curtis et al. U.S. medical eligibility criteria for contraceptive use, 2016. MMWR Recomm Rep 2016; 65:1.
- MF Gallo et al. 20 μg versus >20 μg estrogen combined oral contraceptives for contraception. Cochrane Database Syst Rev 2013; 8:CD003989.
- A Edelman et al. Continuous or extended cycle vs. cyclic use of combined hormonal contraceptives for contraception. Cochrane Database Syst Rev 2014; 7:CD004695.
- L Iversen et al. Association between contemporary hormonal contraception and ovarian cancer in women of reproductive age in Denmark: prospective, nationwide cohort study. BMJ 2018; 362:k3609.
- AR Brant et al. Non-contraceptive benefits of hormonal contraception: established benefits and new findings. Curr Obstet Gynecol Rep 2017; 6:109.
- R Słopień et al. Use of oral contraceptives for management of acne vulgaris and hirsutism in women of reproductive and late reproductive age. Menopause Rev 2018; 17:1.
- Three new oral contraceptives. Med Lett Drugs Ther 2006; 48:77.
- MK Trivedi et al. A review of hormone-based therapies to treat adult acne vulgaris in women. Int J Womens Dermatol 2017; 3:44.
- Y Vinogradova et al. Use of combined oral contraceptives and risk of venous thromboembolism: nested case-control studies using the QResearch and CPRD databases. BMJ 2015; 350:h2135.
- C Oedingen et al. Systematic review and meta-analysis of the association of combined oral contraceptives on the risk of venous thromboembolism: the role of the progestogen type and estrogen dose. Thromb Res 2018; 165:68.
- LS Mørch et al. Contemporary hormonal contraception and the risk of breast cancer. N Engl J Med 2017; 377:2228.
- CW Skovlund et al. Association of hormonal contraception with depression. JAMA Psychiatry 2016; 73:1154.
- FDA. Labeling for combined hormonal contraceptives: guidance for industry. December 2017. Available at www.fda.gov. Accessed September 27, 2018.
- KB Simmons et al. Drug interactions between non-rifamycin antibiotics and hormonal contraception: a systematic review. Am J Obstet Gynecol 2018; 218:88.
- ACOG. Committee opinion No. 602: depot medroxyprogesterone acetate and bone effects. Obstet Gynecol 2014; 123:1398.
- ACOG. Practice bulletin No. 186: long-acting reversible contraception: implants and intrauterine devices. Obstet Gynecol 2017; 130:e251.
- In brief: etonogestrel (Nexplanon) contraceptive implant. Med Lett Drugs Ther 2012; 54:12.
- KM Curtis and JF Peipert. Long-acting reversible contraception. N Engl J Med 2017; 376:461.
- JP Wu et al. Long-acting reversible contraception - highly efficacious, safe, and underutilized. JAMA 2018; 320:397.
- VK Cortessis et al. Intrauterine device use and cervical cancer risk: a systematic review and meta-analysis. Obstet Gynecol 2017; 130:1226.
- I Sivin. Utility and drawbacks of continuous use of a copper T IUD for 20 years. Contraception 2007; 75(6 Suppl):S70.
- Liletta - a third levonorgestrel-releasing IUD. Med Lett Drugs Ther 2015; 57:99.
- Kyleena - another hormonal IUD. Med Lett Drugs Ther 2017; 59:38.
- ACOG. Practice bulletin summary No. 152: emergency contraception. Obstet Gynecol 2015; 126:685.
- ND Goldstuck and D Wildemeersch. Practical advice for emergency IUD contraception in young women. Obstet Gynecol Int 2015; 2015:986439.
- DT Baird. Emergency contraception: how does it work? Reprod Biomed Online 2009; 18 Suppl 1:32.
- A Glasier. The rationale for use of ulipristal acetate as first line in emergency contraception: biological and clinical evidence. Gynecol Endocrinol 2014; 30:688.
- G Piaggio et al. Effect on pregnancy rates of the delay in the administration of levonorgestrel for emergency contraception: a combined analysis of four WHO trials. Contraception 2011; 84:35.
- K Cleland et al. Emergency contraception review: evidence-based recommendations for clinicians. Clin Obstet Gynecol 2014; 57:741.
The Medical Letter is a subscriber-funded nonprofit organization that publishes critical appraisals of new prescription drugs and comparative reviews of drugs for common diseases.
Would you like to read the rest of this article? Gain access below.
Subscribe
Subscriptions to The Medical Letter on Drugs and Therapeutics include:
- Print version published and mailed biweekly (26 issues/year)
- Unlimited online access to current and past issues (1988 - present)
- Mobile App for iOS, Android, and Kindle Fire
- FREE online per issue CME/CE
Purchase this article:
Title: Choice of Contraceptives
Article code: 1557a
Electronic, downloadable article - $45
Article code: 1557a
Electronic, downloadable article - $45
Gain access through your organization
Ask your librarian to consider an Institutional Subscription to The Medical Letter.
Recommend to your librarian
